These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 15180335)
1. Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes. Ito K; Houston JB Pharm Res; 2004 May; 21(5):785-92. PubMed ID: 15180335 [TBL] [Abstract][Full Text] [Related]
2. A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes. Riley RJ; McGinnity DF; Austin RP Drug Metab Dispos; 2005 Sep; 33(9):1304-11. PubMed ID: 15932954 [TBL] [Abstract][Full Text] [Related]
3. First-in-Human Predictions of Hepatic Clearance for Drugs With the Well-Stirred Model: Comparative Assessment Between Models of Fraction Unbound Based Either on the Free Drug Hypothesis, Albumin-Facilitated Hepatic Uptake or Dynamic Binding Kinetics. Poulin P J Pharm Sci; 2024 Aug; 113(8):2641-2650. PubMed ID: 38796154 [TBL] [Abstract][Full Text] [Related]
4. Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans. Naritomi Y; Terashita S; Kimura S; Suzuki A; Kagayama A; Sugiyama Y Drug Metab Dispos; 2001 Oct; 29(10):1316-24. PubMed ID: 11560875 [TBL] [Abstract][Full Text] [Related]
5. Predicting Clearance with Simple and Permeability-Limited Physiologically Based Pharmacokinetic Frameworks: Comparison of Well-Stirred, Dispersion, and Parallel-Tube Liver Models. Nagar S; Parise R; Korzekwa K Drug Metab Dispos; 2024 Sep; 52(10):1060-1072. PubMed ID: 39084881 [TBL] [Abstract][Full Text] [Related]
6. Relationship between passive permeability, efflux, and predictability of clearance from in vitro metabolic intrinsic clearance. Huang L; Berry L; Ganga S; Janosky B; Chen A; Roberts J; Colletti AE; Lin MH Drug Metab Dispos; 2010 Feb; 38(2):223-31. PubMed ID: 19875499 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the human prediction of clearance from hepatocyte and microsome intrinsic clearance for 52 drug compounds. Sohlenius-Sternbeck AK; Afzelius L; Prusis P; Neelissen J; Hoogstraate J; Johansson J; Floby E; Bengtsson A; Gissberg O; Sternbeck J; Petersson C Xenobiotica; 2010 Sep; 40(9):637-49. PubMed ID: 20624033 [TBL] [Abstract][Full Text] [Related]
8. Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches. Ito K; Houston JB Pharm Res; 2005 Jan; 22(1):103-12. PubMed ID: 15771236 [TBL] [Abstract][Full Text] [Related]
9. Utility of hepatocytes in predicting drug metabolism: comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro. Naritomi Y; Terashita S; Kagayama A; Sugiyama Y Drug Metab Dispos; 2003 May; 31(5):580-8. PubMed ID: 12695346 [TBL] [Abstract][Full Text] [Related]
10. Prediction of human metabolic clearance from in vitro systems: retrospective analysis and prospective view. Hallifax D; Foster JA; Houston JB Pharm Res; 2010 Oct; 27(10):2150-61. PubMed ID: 20661765 [TBL] [Abstract][Full Text] [Related]
11. In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance. Soars MG; Burchell B; Riley RJ J Pharmacol Exp Ther; 2002 Apr; 301(1):382-90. PubMed ID: 11907196 [TBL] [Abstract][Full Text] [Related]
12. Impact of input parameters on the prediction of hepatic plasma clearance using the well-stirred model. Wan H; Bold P; Larsson LO; Ulander J; Peters S; Löfberg B; Ungell AL; Någård M; Llinàs A Curr Drug Metab; 2010 Sep; 11(7):583-94. PubMed ID: 20629632 [TBL] [Abstract][Full Text] [Related]
13. Scaling factors to relate drug metabolic clearance in hepatic microsomes, isolated hepatocytes, and the intact liver: studies with induced livers involving diazepam. Carlile DJ; Zomorodi K; Houston JB Drug Metab Dispos; 1997 Aug; 25(8):903-11. PubMed ID: 9280396 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance. Brown HS; Griffin M; Houston JB Drug Metab Dispos; 2007 Feb; 35(2):293-301. PubMed ID: 17132764 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of hepatic clearance prediction using in vitro data: emphasis on fraction unbound in plasma and drug ionisation using a database of 107 drugs. Hallifax D; Houston JB J Pharm Sci; 2012 Aug; 101(8):2645-52. PubMed ID: 22700322 [TBL] [Abstract][Full Text] [Related]
16. Correlation of intrinsic in vitro and in vivo clearance for drugs metabolized by hepatic UDP-glucuronosyltransferases in rats. Nakamori F; Naritomi Y; Furutani M; Takamura F; Miura H; Murai H; Terashita S; Teramura T Drug Metab Pharmacokinet; 2011; 26(5):465-73. PubMed ID: 21727754 [TBL] [Abstract][Full Text] [Related]
17. Use of intrinsic clearance for prediction of human hepatic clearance. Chao P; Uss AS; Cheng KC Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):189-98. PubMed ID: 20073997 [TBL] [Abstract][Full Text] [Related]
18. Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance. Fagerholm U J Pharm Pharmacol; 2007 Jun; 59(6):803-28. PubMed ID: 17637173 [TBL] [Abstract][Full Text] [Related]
19. Prediction of total hepatic clearance by combining metabolism, transport, and permeability data in the in vitro-in vivo extrapolation methods: emphasis on an apparent fraction unbound in liver for drugs. Poulin P J Pharm Sci; 2013 Jul; 102(7):2085-95. PubMed ID: 23613473 [TBL] [Abstract][Full Text] [Related]
20. On the prediction of hepatic clearance using the diluted plasma in metabolic stability assay. Berezhkovskiy LM; Khojasteh SC; Halladay JS; Hop CE J Pharm Sci; 2009 Jun; 98(6):1922-7. PubMed ID: 18837013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]